Pregnancy, pre-eclampsia and disseminated intravascular coagulation

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Pathophysiology

Background:

• Pre-eclampsia is a serious pregnancy complication.
• The role of disseminated intravascular coagulation (DIC) in pre-eclampsia is debated.
• Understanding coagulation abnormalities is crucial for managing pre-eclampsia.

Purpose of the Study:

• To investigate the haemostatic mechanism in pre-eclampsia.
• To determine if disseminated intravascular coagulation (DIC) occurs in pre-eclampsia.
• To evaluate the efficacy of sodium pentosan polysulphate in pre-eclampsia management.

Main Methods:

• Prospective evaluation of haemostasis in normal primigravidas and those with pre-eclampsia.
• Coagulation tests were performed.
• Platelet factor 3 availability and aggregation against ADP were measured before and after treatment with sodium pentosan polysulphate.

Main Results:

• Prolongation of bleeding time was the only observed coagulation abnormality.
• Significant disseminated intravascular coagulation (DIC) was not supported by the data.
• Sodium pentosan polysulphate reduced platelet factor 3 availability and ADP-induced aggregation but did not improve clinical outcomes.

Conclusions:

• Significant disseminated intravascular coagulation (DIC) is unlikely to be a major factor in pre-eclampsia.
• Sodium pentosan polysulphate is ineffective for managing established pre-eclampsia.
• Further research into the haemostatic changes in pre-eclampsia is warranted.